Independent Advisor Alliance’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.5K	Buy	10,053 +53	+0.5%	+$168	﹤0.01%	1577
2025 Q4	$37K	Hold	10,000	–	–	﹤0.01%	983
2025 Q3	$26.5K	Hold	10,000	–	–	﹤0.01%	934
2025 Q2	$9.84K	Sell	10,000 -1,356	-12%	-$1.36K	﹤0.01%	887
2025 Q1	$16.4K	Sell	11,356 -2,644	-19%	-$4.87K	﹤0.01%	805
2024 Q4	$30.8K	Buy	14,000 +1,000	+8%	+$2.33K	﹤0.01%	1341
2024 Q3	$21.4K	Hold	13,000	–	–	﹤0.01%	699
2024 Q2	$28.9K	Buy	13,000 +1,500	+13%	+$3.53K	﹤0.01%	692
2024 Q1	$30.8K	Buy	11,500 +1,500	+15%	+$3.65K	﹤0.01%	690
2023 Q4	$29.9K	Hold	10,000	–	–	﹤0.01%	668
2023 Q3	$9.8K	Hold	10,000	–	–	﹤0.01%	646
2023 Q2	$13.9K	Hold	10,000	–	–	﹤0.01%	664
2023 Q1	$15.9K	Sell	10,000 -350	-3%	-$1.81K	﹤0.01%	663
2022 Q4	$64	Buy	10,350 +144	+1%	+$1.03K	﹤0.01%	399
2022 Q3	$68K	Sell	10,206 -100	-1%	-$687	﹤0.01%	602
2022 Q2	$66K	Buy	10,306 +306	+3%	+$1.74K	﹤0.01%	595
2022 Q1	$46K	Hold	10,000	–	–	﹤0.01%	645
2021 Q4	$50K	Sell	10,000 -1,500	-13%	-$12K	﹤0.01%	656
2021 Q3	$139K	Buy	+11,500	New	+$167K	0.01%	601